IRC review | Investigator review | |||||
---|---|---|---|---|---|---|
RECIST v1.1 | mRECIST | iRECIST | RECIST v1.1 | mRECIST | iRECIST | |
Confirmed objective response, n (%) [95% CIa] | 24 (38.7) [26.6, 51.9] | 29 (46.8) [34.0, 59.9] | 24 (38.7) [26.6, 51.9] | 26 (41.9) [29.5, 55.2] | 29 (46.8) [34.0, 59.9] | 27 (43.5) [31.0, 56.7] |
BOR/iBOR, n (%) | ||||||
CR/iCR | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.6) | 1 (1.6) | 1 (1.6) |
PR/iPR | 24 (38.7) | 29 (46.8) | 24 (38.7) | 25 (40.3) | 28 (45.2) | 26 (41.9) |
SD/iSD | 32 (51.6) | 27 (43.5) | 32 (51.6) | 27 (43.5) | 24 (38.7) | 28 (45.2) |
PD | 5 (8.1) | 5 (8.1) | n/a | 8 (12.9) | 8 (12.9) | n/a |
iUPD | n/a | n/a | 2 (3.2) | n/a | n/a | 2 (3.2) |
iCPD | n/a | n/a | 3 (4.8) | n/a | n/a | 4 (6.5) |
Not assessableb | 1 (1.6) | 1 (1.6) | 1 (1.6) | 1 (1.6) | 1 (1.6) | 1 (1.6) |
DCR, n (%) [95% CIa] | 56 (90.3) [80.1, 96.4] | 56 (90.3) [80.1, 96.4] | 56 (90.3) [80.1, 96.4] | 53 (85.5) [74.2, 93.1] | 53 (85.5) [74.2, 93.1] | 55 (88.7) [78.1, 95.3] |